A rapid COVID-19 screening test developed in Israel will be used to screen passengers in several European airports. The test involves gargling with a small amount of special mouthwash and spitting it into a test tube. Virusight Diagnostic, a newly formed Artificial Intelligence health care venture between Sheba Medical Center's ARC Innovation Center and Newsight Imaging, has signed a strategic letter of intent for rapid screening of airline passengers with ICTS Europe, a security provider at major airports in 23 countries, Newsight announced in a statement on its website. A trial of the test last month involving some 400 people at Sheba showed about 95% accuracy. “Tests will be immediate, affordable and monitored, so that airports and airlines can optimize the level of safety by mitigating the risk of COVID-19 infection,” the statement said. The gargle test uses SpectraLIT, Newsight Imaging's portable and accurate spectral analysis device, to determine the presence of the COVID-19 virus. var theUrl = document.URL;var theUrlArray = theUrl.split("//");var theUrlpre = theUrlArray[1];var theUrlpostArray = theUrlpre.split("/");var theUrlpost = theUrlpostArray[0];(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,'script','//www.google-analytics.com/analytics.js','ga');ga('create', 'UA-2449829-1', theUrlpost, {'name':'uniqueTrackerName'});ga('uniqueTrackerName.send', 'pageview');
